Fonar Corporation (FONR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Fonar Corporation (FONR:NASDAQ), powered by AI.

Current Price
$18.80
P/E Ratio
14.0
Market Cap
117M
Sector
Healthcare
What is the Fonar Corporation stock price forecast?

Fonar Corporation is currently trading at $18.80. View real-time AI analysis on Alpha Lenz.

What is Fonar Corporation insider trading activity?

View the latest insider trading data for Fonar Corporation on Alpha Lenz.

What is Fonar Corporation's P/E ratio?

Fonar Corporation's P/E ratio is 14.0.

Fonar Corporation

NASDAQ · FONR
$18.80
Ask about Fonar Corporation's future dividend policy...
Alpha Chat Insight

Fonar Corporation trades at a P/E of 14.0 (undervalued) with modest ROE of 4.9%.

Ask for details

Company Overview

Fonar Corporation is a technology company primarily focused on the development and manufacturing of Magnetic Resonance Imaging (MRI) scanners and related medical imaging equipment. Its flagship products include the UPRIGHT Multi-Position MRI and the Fonar 360 toroidal scanner, which offer unique imaging capabilities by allowing patients to be scanned in various positions, thus enabling more accurate diagnoses. Founded in 1978, Fonar Corporation was the pioneer in the field, credited with creating the first MRI scanner, thereby revolutionizing medical diagnostics through non-invasive imaging techniques. The company mainly serves the healthcare sector, impacting hospitals, diagnostic centers, and medical practices that rely on cutting-edge imaging technology to improve patient outcomes. With its headquarters in Melville, New York, Fonar Corporation has positioned itself as a pivotal entity in the medical imaging industry, continually driving advancements in MRI technology. Its role in the financial market reflects its significance in healthcare innovation, catering to the needs of healthcare professionals seeking advanced diagnostic solutions. By maintaining a focus on research and development, Fonar Corporation continues to influence technological progress in the medical field.

CEOMr. Timothy R. Damadian M.D.
SectorHealthcare
IndustryDiagnostics & Research
Employees535

Company Statistics

FY 2025

Profile

$116.76MMarket Cap
$104.35MRevenue
0.00Shares Out
535Employees

Margins

41.12%Gross
15.65%EBITDA
11.12%Operating
13.21%Pre-Tax
10.23%Net

Valuation

14.01P/E
0.68P/B
1.12EV/Sales
5.32EV/EBITDA
15.68P/FCF

Growth (CAGR)

2.26%Rev 3Yr
4.02%Rev 5Yr
-19.22%Op Inc 3Yr
-3.21%Op Inc 5Yr
-14.76%Net Inc 3Yr
-1.83%Net Inc 5Yr

Returns

4.95%ROA
4.92%ROE
6.40%ROIC

Financial Health

$56.33MCash & Cash Equivalents
$469.62KNet Debt
35.48%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Fonar Corporation (ticker: FONR) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 535 employees. Market cap is $117M.

The current price is $18.8 with a P/E ratio of 14.01x and P/B of 0.68x.

ROE is 4.92% and operating margin is 11.12%. Annual revenue is $104M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Fonar Corporation (Healthcare) Stock Forecast & Analysis $18.80 | Alpha Lenz